{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:41:54Z","timestamp":1759405314139,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.09.027","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T01:52:46Z","timestamp":1632275566000},"page":"6391-6397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Concordance of self-reported varicella history and serology among adolescent and adult refugee patients at a primary care clinic in Toronto, Canada"],"prefix":"10.1016","volume":"39","author":[{"given":"Frank","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-0694","authenticated-orcid":false,"given":"Vanessa","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meb","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Redditt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.09.027_b0005","unstructured":"United Nations High Commissioner for Refugees. Global Trends - Forced Displacement in 2019. [September 01, 2020]; Available from: https:\/\/www.unhcr.org\/5ee200e37.pdf."},{"key":"10.1016\/j.vaccine.2021.09.027_b0010","unstructured":"Canada Open Government Portal. Canada - Admissions of Permanent Residents by Country of Citizenship and Immigration Category. [September 01, 2020.213Z]; Available from: https:\/\/open.canada.ca\/data\/en\/dataset\/f7e5498e-0ad8-4417-85c9-9b8aff9b9eda."},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.027_b0015","doi-asserted-by":"crossref","first-page":"E952","DOI":"10.1503\/cmaj.090287","article-title":"Migration and health in Canada: health in the global village","volume":"183","author":"Gushulak","year":"2011","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.027_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/20477724.2017.1281374","article-title":"Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence","volume":"111","author":"Mipatrini","year":"2017","journal-title":"Pathog Glob Health"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.027_b0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.21101\/cejph.a5543","article-title":"Vaccination rates for Syrian population under temporary protection in Turkey","volume":"28","author":"\u00d6zta\u015f","year":"2020","journal-title":"Cent Eur J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.027_b0030","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2021.09.027_b0035","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0163-4453(17)30188-3","article-title":"Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?","volume":"74","author":"Gershon","year":"2017","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.027_b0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/01443615.2015.1127905","article-title":"Congenital varicella syndrome: a systematic review","volume":"36","author":"Ahn","year":"2016","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.027_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.104.1.1","article-title":"Cost of chickenpox in Canada: part I. Cost of uncomplicated cases","volume":"104","author":"Law","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.027_b0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/21645515.2015.1008880","article-title":"Trends in varicella mortality in the United States: data from vital statistics and the national surveillance system","volume":"11","author":"Leung","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.vaccine.2021.09.027_b0055","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1080\/21645515.2018.1480283","article-title":"Update on trends in varicella mortality during the varicella vaccine era-United States, 1990\u20132016","volume":"14","author":"Leung","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.027_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10903-015-0313-y","article-title":"Risk factors for varicella susceptibility among refugees to Toronto, Canada","volume":"19","author":"Cadieux","year":"2017","journal-title":"J Immigr Minor Health"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.027_b0065","doi-asserted-by":"crossref","first-page":"E824","DOI":"10.1503\/cmaj.090313","article-title":"Evidence-based clinical guidelines for immigrants and refugees","volume":"183","author":"Pottie","year":"2011","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.027_b0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10903-013-9946-x","article-title":"Seroprevalence of varicella-zoster virus in five US-bound refugee populations","volume":"17","author":"Leung","year":"2015","journal-title":"J Immigr Minor Health"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.027_b0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40121-017-0169-7","article-title":"Measles, rubella and varicella IgG seroprevalence in a large refugee cohort in Germany in 2015: a cross-sectional study","volume":"6","author":"Jablonka","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2021.09.027_b0080","doi-asserted-by":"crossref","unstructured":"Toikkanen SE, Baillot A, Dreesman J, Mertens E. Seroprevalence of antibodies against measles, rubella and varicella among asylum seekers arriving in Lower Saxony, Germany, November 2014-October 2015. Int J Environ Res Public Health 2016;13(7). https:\/\/doi.org\/10.3390\/ijerph13070650.","DOI":"10.3390\/ijerph13070650"},{"issue":"7","key":"10.1016\/j.vaccine.2021.09.027_b0085","first-page":"e303","article-title":"Health status of newly arrived refugees in Toronto, Ont: Part 1: infectious diseases","volume":"61","author":"Redditt","year":"2015","journal-title":"Can Fam Physician"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.027_b0090","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1017\/S0950268813002768","article-title":"Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada","volume":"142","author":"Greenaway","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.09.027_b0095","doi-asserted-by":"crossref","first-page":"101465","DOI":"10.1016\/j.tmaid.2019.101465","article-title":"Varicella outbreak among the Rohingya refugees in Bangladesh: lessons learned and potential prevention strategies","volume":"31","author":"Hsan","year":"2019","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2021.09.027_b0100","doi-asserted-by":"crossref","unstructured":"Vairo F, Di Bari V, Panella V, Quintavalle G, Torchia S, Serra MC et al. An outbreak of chickenpox in an asylum seeker centre in Italy: outbreak investigation and validity of reported chickenpox history, December 2015-May 2016. Euro Surveill 2017;22(46). https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.46.17-00020.","DOI":"10.2807\/1560-7917.ES.2017.22.46.17-00020"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.027_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw042","article-title":"Varicella outbreak in Sudanese refugees from Calais","volume":"23","author":"Lesens","year":"2016","journal-title":"J Travel Med"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.027_b0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","article-title":"Varicella vaccination - the global experience","volume":"16","author":"Wutzler","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.09.027_b0115","unstructured":"Public Health Agency of Canada. Canadian Immunization Guide."},{"key":"10.1016\/j.vaccine.2021.09.027_b0120","unstructured":"Public Health Agency of Canada. Varicella (chickenpox) vaccine: Canadian Immunization Guide. [February 07, 2021.194Z]; Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-24-varicella-chickenpox-vaccine.html."},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.027_b0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/INF.0000000000002162","article-title":"Rate of recurrence of adverse events following immunization: results of 19 years of surveillance in Quebec, Canada","volume":"38","author":"Zafack","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.027_b0130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/512673","article-title":"Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis","volume":"44","author":"Merrett","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2021.09.027_b0135","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1016\/j.vaccine.2004.04.024","article-title":"Comparison of varicella history with presence of varicella antibody in refugees","volume":"22","author":"Christiansen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.09.027_b0140","unstructured":"Public Health Ontario. Laboratory Services on Varicella Serology Testing. [October 25, 2019]; Available from: https:\/\/www.publichealthontario.ca\/en\/laboratory-services\/test-information-index\/varicella-serology#.VQ1-nGf-PHI."},{"key":"10.1016\/j.vaccine.2021.09.027_b0145","unstructured":"Public Health Ontario. Measles, Mumps, Rubella (MMR) and Varicella\u2010Zoster Virus (VZV)Immune Status Serology. [May 02, 2020]; Available from: https:\/\/www.publichealthontario.ca\/-\/media\/documents\/lab\/lab-sd-090-measlesmumps-rubella-varicella-zostervirus-immuneserology.pdf?la=en."},{"key":"10.1016\/j.vaccine.2021.09.027_b0150","unstructured":"Atlas of Sustainable Development Goals 2018: From World Development Indicators. The World Bank; 2018."},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.027_b0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1473-3099(20)30277-2","article-title":"Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study","volume":"21","author":"Greenaway","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.027_b0160","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.vaccine.2018.01.079","article-title":"Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016","volume":"36","author":"Freidl","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2021.09.027_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz035","article-title":"Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional study","volume":"26","author":"Staehelin","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2021.09.027_b0170","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 global summary. [November 12, 2019]; Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules."},{"issue":"9","key":"10.1016\/j.vaccine.2021.09.027_b0175","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1128\/CVI.00250-14","article-title":"Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay","volume":"21","author":"Cohen","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"issue":"7-8","key":"10.1016\/j.vaccine.2021.09.027_b0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine","volume":"19","author":"Sharrar","year":"2000","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2021.09.027_b0185","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.vaccine.2017.03.054","article-title":"Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection","volume":"35","author":"Duncan","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:36Z","timestamp":1759402956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21012068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":37,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X21012068"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concordance of self-reported varicella history and serology among adolescent and adult refugee patients at a primary care clinic in Toronto, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}